Novel insights into immune checkpoints in HIV/SHIV infection: from SHIV SF162P3 -infected elite controllers to therapeutic strategy
Journal of Virology · 2025
DOI: 10.1128/jvi.00785-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Yuting Sun und 15 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Ins…. Hauptthemen laut MEDLINE: Simian Acquired Immunodeficiency Syndrome, Simian Immunodeficiency Virus, HIV Infections, HIV-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality.
Abstract (Originalsprache)
During chronic HIV-1 infection, the upregulation of immune checkpoints (ICs) on lymphocytes contributes to persistent immune dysfunction, T-cell exhaustion, and inadequate virological control, highlighting the potential role of ICs in HIV functional cure strategy. Despite extensive research on ICs, the expression dynamics and immunological impact of ICs in natural HIV/SHIV infection, particularly among antiretroviral therapy (ART)-free elite controllers (ECs), remain poorly understood. In this study, we monitored a cohort of SHIV SF162P3 -infected rhesus macaques (RMs), identifying four ECs and four progressors (PGs) through longitudinal evaluation. We observed low-level expression of ICs in both peripheral blood and lymph nodes of ECs, characterized by a particularly pronounced restriction in the expression of TIGIT and BTLA. This attenuated IC profile correlated with enhanced T-cell functionality, reduced exhaustion markers, and reduced viral reservoirs in peripheral and lymphoid tissues. Transcriptomic profiling revealed that TIGIT is a critical checkpoint marker involved in multiple synergistic cofunctions related to HIV/SIV-specific immune regulation. Collectively, our findings establish a dual role for ICs in perpetuating T-cell exhaustion and viral reservoir persistence, paving the way for IC blockade in future HIV cure strategies. IMPORTANCE Rhesus macaques spontaneously controlling simian-human immunodeficiency virus (SHIV) without antiretroviral therapy have low-level expression of immune molecules (ICs), characterized by TIGIT and BTLA. These molecules are linked to enhanced immune function and reduced viral presence in peripheral blood and lymph nodes. Transcriptomic profiling revealed that TIGIT is a critical checkpoint marker involved in multiple synergistic cofunctions related to HIV/SIV-specific immune regulation in both humans and macaques. Blocking TIGIT improved polyfunctional T-cell responses, thereby offering a potential new treatment strategy and providing critical insights for developing a functional HIV cure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Scienc…
- Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, the University of Western Australia, Perth, Western Australia, Australia.
- National Center of Technology Innovation for animal model, National Human Diseases Animal Model Resource Center, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences, Beijing, China.
- Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- State Key Laboratory of Respiratory Health and Multimorbidity, Key Laboratory of Pathogen Infection Prevention and Control (Peking Union Medical College), Ministry of Education, Institute of Laboratory Animal Science, C…
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/ STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
ORCID-Profile: Peiwen Liu, Dan Li, Rui Hou, Jing Xue
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
- CAMS Innovation Fund for Medical Science
Zitieren
APA
Sun, Y., Yang, C., Liu, P., Cong, Z., Luo, J., Tong, L., Zhang, J., Lu, J., Jia, Z., Zhu, L., Lu, Q., Chen, T., Wei, Q., Li, D., Hou, R., & Xue, J. (2025). Novel insights into immune checkpoints in HIV/SHIV infection: from SHIV SF162P3 -infected elite controllers to therapeutic strategy. Journal of Virology. https://doi.org/10.1128/jvi.00785-25
Vancouver
Sun Y, Yang C, Liu P, Cong Z, Luo J, Tong L, et al. Novel insights into immune checkpoints in HIV/SHIV infection: from SHIV SF162P3 -infected elite controllers to therapeutic strategy. Journal of Virology. 2025. doi:10.1128/jvi.00785-25
BibTeX
@article{Sun2025,
author = {Sun, Yuting and Yang, Chenbo and Liu, Peiwen and Cong, Zhe and Luo, Jiahui and Tong, Ling and Zhang, Jingjing and Lu, Jiahan and Jia, Ziqing and Zhu, Lin and Lu, Qiuhan and Chen, Ting and Wei, Qiang and Li, Dan and Hou, Rui and Xue, Jing},
title = {Novel insights into immune checkpoints in HIV/SHIV infection: from SHIV SF162P3 -infected elite controllers to therapeutic strategy},
journal = {Journal of Virology},
year = {2025},
doi = {10.1128/jvi.00785-25}
}
EUVIMED